ICD-10-CM Billable Code

D00.2

Carcinoma in situ of stomach

Clinical Classification Guidelines

Medical Intelligence & Overview

Carcinoma in situ of the stomach is an early form of stomach cancer where abnormal cells are confined to the innermost layer of the stomach lining. Also known as 'in situ' carcinoma, this condition indicates that the cancer has not yet invaded deeper tissues or spread to other parts of the body. Recognizing and diagnosing this early stage is crucial for effective treatment and better outcomes.

Causes & Symptoms

Clinical Causes: Genetic factors and family history of stomach cancer Chronic infection with Helicobacter pylori bacteria Long-term inflammation of the stomach lining (gastritis) Diet high in smoked, salted, or pickled foods smoking and excessive alcohol consumption Previous history of stomach ulcers or other gastric conditions Exposure to certain environmental toxins

Key Symptoms: Generally, carcinoma in situ of the stomach may not cause noticeable symptoms in early stages. When symptoms do occur, they may include: - Persistent indigestion or heartburn - Unexplained nausea or vomiting - Feeling full after eating small amounts - Unintentional weight loss - Abdominal discomfort or pain - Bleeding or anemia, leading to weakness and fatigue

Diagnostic & Treatment

Diagnosis Path: Endoscopy: A flexible tube with a camera is inserted into the stomach to visualize and identify abnormal areas. Biopsy: Tissue samples are taken during the endoscopy to examine the cellular characteristics under a microscope. Imaging tests: Procedures such as CT scans or upper GI series may be used to assess the extent and rule out invasion or spread. Laboratory tests: Blood tests may help detect anemia or other indications of bleeding or inflammation.

Treatment Protocols: Endoscopic mucosal resection (EMR): A minimally invasive procedure to remove the lesion during endoscopy. Endoscopic submucosal dissection (ESD): A more advanced method suitable for larger or more complex lesions. Monitoring and follow-up: Regular surveillance with endoscopy to detect any recurrence or development of new lesions. Lifestyle modifications: Changes in diet, quitting smoking, and decreasing alcohol intake to reduce risk factors.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is D00.2 a billable ICD-10 code?
Yes, D00.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report D00.2?
Clinical documentation must specify the nature of Carcinoma in situ of stomach and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

stomach carcinoma